Diabetes Technologies, Inc.
United StatesFDA applicant, unverified
- Devices
- 2
What Diabetes Technologies, Inc. makes
Diabetes Technologies, Inc. manufactures the ACCU-BASE Hemoglobin A1C Sample Collection Kit, a device designed for collecting blood samples to measure long-term blood glucose levels.
The company’s portfolio is regulated under FDA’s Class II device classification, with the ACCU-BASE Hemoglobin A1C Sample Collection Kit listed via the 510(k) pathway. The manufacturer is based in the United States.
Catalogue
Accu-Base Hemoglobin A1C Sample Collection Kit Ref K983172
Regimes: 510(k) Registry: 510(k)Accu-Base Hemoglobin A1C Sample Collection Kit Ref K013465
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Diabetes Technologies, Inc. have in the registry?
The registry currently lists 2 devices for Diabetes Technologies, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Diabetes Technologies, Inc.'s devices?
Among its 2 most recently registered devices, Diabetes Technologies, Inc. has devices listed in FDA 510(k) (2 devices).
What risk classes do Diabetes Technologies, Inc.'s devices fall under?
Among its 2 most recently registered devices, the classes recorded for Diabetes Technologies, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Diabetes Technologies, Inc. in the registry?
The most recently registered devices listed for Diabetes Technologies, Inc. include ACCU-BASE HEMOGLOBIN A1C SAMPLE COLLECTION KIT.